Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Boan Biotech Announces 2024 Half Year Results: Revenue Grows by 39%, Net Profit Increases by RMB 180 Million 2024-08-27 22:55
Boan Biotech's Two Innovative Drugs Targeting Claudin 18.2 Granted ODD by FDA 2023-12-27 20:50
First Patient Enrolled in Phase III Clinical Trial of Boan Biotech's Nivolumab Injection 2023-10-30 14:51
Boan Biotech's BA1202 Approved for Clinical Trial 2023-05-16 22:02
Patient Enrollment Completed for Phase III Clinical Trial of Boan Biotech's Dulaglutide Injection BA5101 in China 2023-05-15 21:58
First Subject Enrolled in Boan Biotech's International Multi-Center Phase 3 Clinical Study for Its Denosumab BA6101 & BA1102 2023-05-04 14:40
Boan Biotech's Biologics License Application for Boyounuo® (Bevacizumab Injection) Accepted in Brazil 2023-04-11 20:19
Boan Biotech Announces 2022 Financial Results 2023-03-27 23:15
1